fbpx

See If You Qualify For COVID pfizer Research Trial

At Palm Beach Research, we have COVID-19 studies enrolling participants now. The purpose of this research study is to evaluate the safety of PF-07321332/ritonavir for the treatment of nonhospitalized, symptomatic, adult participants with COVID-19 who are at low risk of progression to severe illness.

Qualified Participants will receive:

  •  Study-related vaccine at no cost
  •  Study-related medical exams at no cost
  •  Compensation up to $300 for time and travel
3 EASY STEPS

How It Works

Step 1

Step 1

Fill out the form to instantly see if you qualify. You can also give us a call at 561-689-0606.
Step 2

Step 2

A member of our team will reach out shortly and may ask some additional questions. 
Step 3

Step 3

If you’re qualified, you will have the opportunity to schedule an office visit for an exam. 
VACC RSV-006

VACC RSV-006

The purpose of this research study is to demonstrate the efficacy of a single dose of GSK’s RSVPreF3 OA investigational vaccine in adults aged 60 years and above.

RSV-PPD

RSV-PPD

This research study is to evaluate the effectiveness and safety of an oral investigational medication for the treatment of Acute Upper Respiratory Infection.

MIGRAINE SATSUMA

MIGRAINE SATSUMA

The purpose of this research study is to demonstrate the efficacy, safety, and tolerability of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of Migraines.

Subscribe To Our Newsletter

Subscribe to learn more about our clinical research trials, current and upcoming studies. 

Since 1994, Palm Beach Research has only been conducting clinical research studies for Pharmaceutical companies. 

Address

Site Contact

David Scott, MBA, CCRC
President & CEO
Scroll to Top